ORIFARM PI A/S: Financial statements 2019
CVR: 27347177
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
ORIFARM PI A/S (CVR 27347177) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -71,000 and a net result of DKK 191,779,000 compared with DKK 148,979,000 the year before. Equity in the 2019 report amounted to DKK 554,384,000. The solvency ratio was 100%.
- Gross Profit
- DKK -71,000
- Profit/Loss
- DKK 191,779,000
- Equity
- DKK 554,384,000
- Total Assets
- DKK 554,406,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -71K | 191.8M | 554.4M | - |
| 2018 | - | -169K | 149M | 502.6M | - |
| 2017 | - | -174K | 99.7M | 357.5M | - |
| 2016 | - | -203K | 50.1M | 256.8M | - |
| 2015 | - | -27K | 25.3M | 206.2M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
ORIFARM PI A/S has published its annual report for 2018. Gross profit came to DKK -169,000, and the net result was DKK 148,979,000.
As of February 1, 2019, Erik Sandberg has joined the board of directors of ORIFARM PI A/S.
As of February 1, 2019, Thomas Brandhof is registered as adm. dir. of ORIFARM PI A/S.
As of February 1, 2019, Erik Sandberg has stepped down as adm. dir. of ORIFARM PI A/S.
About ORIFARM PI A/S
ORIFARM PI A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Finansielle holdingselskaber. The company was previously named ORIFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -446,000 and a net result of DKK 298,665,000 compared with DKK 320,939,000 the year before. Equity in the 2025 report amounted to DKK 1,391,995,000.